ARCHIVES

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977

Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis

March 24, 1978